Ronan Flippot

Safety and Efficacy of Nivolumab in Brain Metastases From Renal Cell Carcinoma: Results of the GETUG-AFU 26 NIVOREN Multicenter Phase II Study

Ronan Flippot, Cécile Dalban, Brigitte Laguerre et al. · Journal of Clinical Oncology · 2019 · 157 citations · Full text

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

Ziad Bakouny, David A. Braun, Sachet A. Shukla et al. · Nature Communications · 2021 · 154 citations · Full text

Results of a Multicenter Phase II Study of Atezolizumab and Bevacizumab for Patients With Metastatic Renal Cell Carcinoma With Variant Histology and/or Sarcomatoid Features

Bradley A. McGregor, Rana R. McKay, David A. Braun et al. · Journal of Clinical Oncology · 2019 · 142 citations · Full text

Doxorubicin plus dacarbazine, doxorubicin plus ifosfamide, or doxorubicin alone as a first‐line treatment for advanced leiomyosarcoma: A propensity score matching analysis from the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Lorenzo D’Ambrosio, Nathan Touati, Jean‐Yves Blay et al. · Cancer · 2020 · 134 citations · Full text

Clinical Activity and Safety of Cabozantinib for Brain Metastases in Patients With Renal Cell Carcinoma

Laure Hirsch, Nieves Martínez Chanzá, Subrina Farah et al. · JAMA Oncology · 2021 · 93 citations · Full text